Table:
begin	end	state
1	22	cytoplasmic
23	40	transmembrane
41	42	non-cytoplasmic
43	66	transmembrane
67	101	cytoplasmic
102	124	transmembrane
125	129	non-cytoplasmic
130	151	transmembrane
152	159	cytoplasmic
160	183	transmembrane
184	204	non-cytoplasmic
205	227	transmembrane
228	247	cytoplasmic
248	269	transmembrane
270	280	non-cytoplasmic
281	304	transmembrane
305	339	cytoplasmic
340	360	transmembrane
361	365	non-cytoplasmic
366	392	transmembrane
393	411	cytoplasmic
412	430	transmembrane
431	435	non-cytoplasmic
436	454	transmembrane
455	473	cytoplasmic

Input:
>Pf1N1B4_4976 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_4976
MKSDTHEITEQAVLQRTLSNRHIQLMAMGGAIGTGLFMGSGKIIALSGTSIILIYMIIGL
FVYFVMRAMGELLLSNLNFKSFADFAGAYLGPRAAFFLGWSYWLSWSVAVVGDAVVVGGF
FQYWFPDVPAWIPAIGMMLTLFALNVLTVKLFGEVEFWFAIIKIIAVVALISVSVLLIAS
SFVSPTGVTASLTHLLDKQAAFPNGLFGFFAGFQMAIFSFAGTELIGTAAAETRSPEKTL
PKAINSIPLRIILFYVLSLVCIIAVTSWQQVSPNKSPFVELFLIAGFPAAAGIVNFVVLT
SAASSANSGVFSSSRMLFGLADLGNAPGIFRRLSKNSVPLISLAFTTFLMLLGVLLLFII
PEVMTAFTIVSTVSAILVIFTWSTILASYIAYRKARPDLHAQSRYKMPGGVPMAWFSLAF
LAFVLCLLALRPDTRLALCVMPAWFIWLAIAYQFSHFKSRNQASHAAGSLLKE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server